These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 32268883)

  • 1. Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy.
    Zarghamian P; Azarkeivan A; Arabkhazaeli A; Mardani A; Shahabi M
    BMC Med Genet; 2020 Apr; 21(1):75. PubMed ID: 32268883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic study of the hepcidin gene (HAMP) promoter and functional analysis of the c.-582A > G variant.
    Parajes S; González-Quintela A; Campos J; Quinteiro C; Domínguez F; Loidi L
    BMC Genet; 2010 Dec; 11():110. PubMed ID: 21143959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of hepcidin gene expression in blood mononuclear cells with iron overload severity among β-thalassemia major patients.
    Ayatollahi H; Mousavi Nezhad SF; Talebpour A; Badiei Z; Nezami H
    Mol Biol Rep; 2020 Dec; 47(12):9353-9359. PubMed ID: 33231816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of hepcidin promoter c.-582 A>G variant and iron overload in thalassemia major.
    Andreani M; Radio FC; Testi M; De Bernardo C; Troiano M; Majore S; Bertucci P; Polchi P; Rosati R; Grammatico P
    Haematologica; 2009 Sep; 94(9):1293-6. PubMed ID: 19734422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic modifiers of secondary iron overload in beta thalassemia major.
    Athiyarath R; George B; Abraham A; Viswabandya A; Srivastava A; Edison ES
    Blood Cells Mol Dis; 2015 Mar; 54(3):242-3. PubMed ID: 25601433
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepcidin and
    Fekri K; Asle Rasouli N; Tavallai Zavareh SA; Jalil M; Moradi F; Hosseinpour M; Teimori H
    Int J Hematol Oncol Stem Cell Res; 2019 Jan; 13(1):42-48. PubMed ID: 31205627
    [No Abstract]   [Full Text] [Related]  

  • 8. Three most common nonsynonymous UGT1A6*2 polymorphisms (Thr181Ala, Arg184Ser and Ser7Ala) and therapeutic response to deferiprone in β-thalassemia major patients.
    Dadheech S; Rao AV; Shaheen U; Hussien MD; Jain S; Jyothy A; Munshi A
    Gene; 2013 Dec; 531(2):301-5. PubMed ID: 24036429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of different iron chelators in Egyptian children with Beta Thalassemia with iron overload.
    Hagag AA; Hamam MA; Taha OA; Hazaa SM
    Infect Disord Drug Targets; 2015; 15(2):98-105. PubMed ID: 26205801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hepcidin antimicrobial peptide on iron overload in tuberculosis patients.
    Javaheri-Kermani M; Farazmandfar T; Ajami A; Yazdani Y
    Scand J Infect Dis; 2014 Oct; 46(10):693-6. PubMed ID: 25134646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to Start Delivering Iron Chelation Therapy in Newly Diagnosed Severe
    Susanah S; Idjradinata PS; Sari NM; Rakhmilla LE; Sribudiani Y; Trisaputra JO; Moestopo O
    Biomed Res Int; 2020; 2020():8185016. PubMed ID: 33415156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral expression of hepcidin gene in Egyptian β-thalassemia major.
    Aboul-Enein A; El-Beshlawy A; Hamdy M; Shaheen I; El-Saadany Z; Samir A; El-Samie HA
    Gene; 2015 Jun; 564(2):206-9. PubMed ID: 25816754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of mutations in iron regulating genes of beta thalassemia major patients of Khyber Pakhtunkhwa, Pakistan.
    Shah M; Danish L; Khan NU; Zaman F; Ismail M; Hussain M; Pervaiz R; Iqbal A
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1310. PubMed ID: 32588561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of HAMP rs10421768 gene and phenotypic expression of hepcidin; a case-control study among sickle cell anaemia patients in Ghana.
    Appiah SK; Nkansah C; Abbam G; Osei-Boakye F; Mensah K; Bani SB; Chemogo S; Sarpong L; Addae TG; Sefa DB; Croffien RA; Adom L; Rauf ROA; Boadu F; Amoah GA; Chukwurah EF
    PLoS One; 2024; 19(6):e0306194. PubMed ID: 38935685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of the HAMP (c.-582 A>G) Polymorphism in Iron Deficiency in Saudi Arabia.
    Al-Amer O; Alsharif KF
    Pak J Biol Sci; 2021 Jan; 24(1):146-150. PubMed ID: 33683041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of hepcidin level with insulin resistance and endocrine glands function in major thalassemia.
    Al-Hakeim HK; Al-Khakani MM; Al-Kindi MA
    Adv Clin Exp Med; 2015; 24(1):69-78. PubMed ID: 25923089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of Growth Differentiation Factor 15 Gene Expression by Curcumin in Patients with Beta-Thalassemia Intermedia.
    Saeidnia M; Ghaderi A; Erfani M; Nowrouzi-Sohrabi P; Shokri M; Tamaddon G; Karimi M; Babashahi M
    Clin Lab; 2024 Jan; 70(1):. PubMed ID: 38213217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.
    Jones E; Pasricha SR; Allen A; Evans P; Fisher CA; Wray K; Premawardhena A; Bandara D; Perera A; Webster C; Sturges P; Olivieri NF; St Pierre T; Armitage AE; Porter JB; Weatherall DJ; Drakesmith H
    Blood; 2015 Jan; 125(5):873-80. PubMed ID: 25519750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.